Celso Pagatpatan Jr.

Current Organisation: CARE Clinical Trial Group Inc.
(some projects in the list below may not be associated with this organisation)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£2,783,477

Apr 24 - Apr 29

A benefit-risk trial of 1-month rifapentine and isoniazid to prevent tuberculosis and reduce morbidity in people with non-communicable multimorbidity

MRC award to University College London and Molebogeng Rangaka

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}